ADIL

Adial Pharmaceuticals, Inc - Common Stock (ADIL)

About Adial Pharmaceuticals, Inc - Common Stock (ADIL)

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Details

Daily high

$2.72

Daily low

$2.54

Price at open

$2.62

52 Week High

$18.90

52 Week Low

$1.31

Market cap

5.8M

Dividend yield

0.00%

Volume

49,149

Avg. volume

1.2M

P/E ratio

-.27

Adial Pharmaceuticals, Inc - Common Stock News